Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (61-70 of 214) with videos related to

Pageof 22
Sort By:
Biochemical and Biophysical Research Communications|November 22, 2005
NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent methodHenry Ogbomo, Anke Hahn, Janina Geiler, et al.
Frontiers in Immunology|June 6, 2018
Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination StrategiesStuart G Masterson, Leslie Lobel, Miles W Carroll, et al.
BMC Genomics|August 17, 2017
Investigating Ebola virus pathogenicity using molecular dynamicsMorena Pappalardo, Francesca Collu, James Macpherson, et al.
Cell Discovery|May 10, 2022
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatmentDenisa Bojkova, Tamara Rothenburger, Sandra Ciesek, et al.
Cell Research|January 22, 2022
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolatesDenisa Bojkova, Marek Widera, Sandra Ciesek, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 29, 2025
Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant bladder cancer cell linesMonika Cuprych-Belter, Agnieszka Łupicka-Słowik, Artur Anisiewicz, et al.
Oncology Reports|February 6, 2020
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapyStefan Vallo, Henner Stege, Maximilian Berg, et al.
Anti-Cancer Drugs|March 20, 2002
Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in miceMartin Michaelis, Jindrich Cinatl, Jaroslav Cinatl, et al.
Cancer Investigation|November 1, 2022
Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug ResistanceJohn Clark-Corrigall, Svetlana Myssina, Martin Michaelis, et al.
International Journal of Pharmaceutics|December 28, 2010
Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cellsKarsten Ulbrich, Martin Michaelis, Florian Rothweiler, et al.
Pageof 22

Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
Biochemical and Biophysical Research Communications|November 22, 2005
NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent methodHenry Ogbomo, Anke Hahn, Janina Geiler, et al.
Frontiers in Immunology|June 6, 2018
Herd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination StrategiesStuart G Masterson, Leslie Lobel, Miles W Carroll, et al.
BMC Genomics|August 17, 2017
Investigating Ebola virus pathogenicity using molecular dynamicsMorena Pappalardo, Francesca Collu, James Macpherson, et al.
Cell Discovery|May 10, 2022
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatmentDenisa Bojkova, Tamara Rothenburger, Sandra Ciesek, et al.
Cell Research|January 22, 2022
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolatesDenisa Bojkova, Marek Widera, Sandra Ciesek, et al.
Cancer Drug Resistance (Alhambra, Calif.)|September 29, 2025
Distinct adaptive strategies to cisplatin, vinblastine and gemcitabine in a panel of chemoresistant bladder cancer cell linesMonika Cuprych-Belter, Agnieszka Łupicka-Słowik, Artur Anisiewicz, et al.
Oncology Reports|February 6, 2020
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapyStefan Vallo, Henner Stege, Maximilian Berg, et al.
Anti-Cancer Drugs|March 20, 2002
Coupling of the antitumoral enzyme bovine seminal ribonuclease to polyethylene glycol chains increases its systemic efficacy in miceMartin Michaelis, Jindrich Cinatl, Jaroslav Cinatl, et al.
Cancer Investigation|November 1, 2022
Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug ResistanceJohn Clark-Corrigall, Svetlana Myssina, Martin Michaelis, et al.
International Journal of Pharmaceutics|December 28, 2010
Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cellsKarsten Ulbrich, Martin Michaelis, Florian Rothweiler, et al.
Pageof 22